Valganciclovir (VGCV) followed by cytomegalovirus (CMV) hyperimmune globulin compared to VGCV for 200 days in abdominal organ transplant recipients at high risk for CMV infection: A prospective, randomized pilot study

Publisher： John Wiley & Sons Inc

E-ISSN： 1399-3062|19|6|tid.12779-tid.12779

ISSN： 1398-2273

Source： TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol.19, Iss.6, 2017-12, pp. : n/a-n/a

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Risk factors and prognostic scale for cytomegalovirus (CMV) infection in CMV‐seropositive patients after allogeneic hematopoietic cell transplantation

By  

TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol. 17, Iss. 4, 2015-08 ,pp. : 510-517

John Wiley & Sons Inc

Access to resources Recommend Favorite

Leukocyte Depleted, Unscreened Blood Products Give a Low Risk for CMV Infection and Disease in CMV Seronegative Allogeneic Stem Cell Transplant Recipients with Seronegative Stem Cell Donors

By Ljungman Per   Larsson Kajsa   Kumlien Gunilla   Aschan Johan   Barkholt Lisbeth   Gustafsson-Jernberg Åsa   Lewensohn-Fuchs Ilona   Ringdén Olle  

Scandinavian Journal of Infectious Diseases, Vol. 34, Iss. 5, 2002-05 ,pp. : 347-350

Informa Healthcare

Access to resources Recommend Favorite

Increased risk of breakthrough infection among cytomegalovirus donor‐positive/recipient‐negative kidney transplant recipients receiving lower‐dose valganciclovir prophylaxis

By  

TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol. 17, Iss. 2, 2015-04 ,pp. : 163-173

John Wiley & Sons Inc

Access to resources Recommend Favorite

Early cytomegalovirus (CMV) gastrointestinal disease that developed 19 days after bone marrow transplantation, with a high-level of CMV antigenemia, of up to 1120 cells/slide

By Yano Shingo   Usui Noriko   Asai Osamu   Dobashi Nobuaki   Sugiyama Katsuki   Saito Takeshi   Sekiguchi Naohiro   Shimizu Akihiro   Iwase Satsuki   Kobayashi Masayuki  

Journal of Infection and Chemotherapy, Vol. 10, Iss. 2, 2004-04 ,pp. : 121-124

Springer Publishing Company

Access to resources Recommend Favorite

Low-Dose Valganciclovir as Preemptive Therapy for Cytomegalovirus Infection Occurring in Allogeneic Stem Cell Transplant Recipients

By  

Acta Haematologica, Vol. 123, Iss. 4, 2010-04 ,pp. : 230-234

Karger

Access to resources Recommend Favorite